These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27 related articles for article (PubMed ID: 16343683)
1. Steatosis in hepatitis C virus infection. Response to anti-viral therapy. Szanto P; Grigorescu M; Dumitru I; Serban A J Gastrointestin Liver Dis; 2006 Jun; 15(2):117-24. PubMed ID: 16802005 [TBL] [Abstract][Full Text] [Related]
2. Erythropoiesis-stimulating agent use for anemia induced by interferon-ribavirin treatment in patients with hepatitis C virus infection is not associated with increased rates of cardiovascular disease, thrombosis, malignancy, or death. Costiniuk CT; Camacho F; Cooper CL Clin Infect Dis; 2008 Jul; 47(2):198-202. PubMed ID: 18532889 [TBL] [Abstract][Full Text] [Related]
3. Therapeutic management of recurrent hepatitis C after liver transplantation. Teixeira R; Menezes EG; Schiano TD Liver Int; 2007 Apr; 27(3):302-12. PubMed ID: 17355450 [TBL] [Abstract][Full Text] [Related]
4. Chronic hepatitis C virus infection in renal transplant: treatment and outcome. Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715 [TBL] [Abstract][Full Text] [Related]
5. Modulation of epitope-specific anti-hepatitis C virus E2 (anti-HCV/E2) antibodies by anti-viral treatment. Mancini N; Carletti S; Perotti M; Romanò L; Craxì RD; Craxì A; Zanetti AR; Clementi M; Burioni R J Med Virol; 2006 Oct; 78(10):1304-11. PubMed ID: 16927283 [TBL] [Abstract][Full Text] [Related]
6. Comparison of hepatitis C treatment patterns in patients with and without psychiatric and/or substance use disorders. Chainuvati S; Khalid SK; Kancir S; Shea M; Edwards J; Sernyak M; Wongcharatrawee S; Garcia-Tsao G J Viral Hepat; 2006 Apr; 13(4):235-41. PubMed ID: 16611189 [TBL] [Abstract][Full Text] [Related]
7. Medical consequences of drug abuse and co-occurring infections: research at the National Institute on Drug Abuse. Khalsa JH; Treisman G; McCance-Katz E; Tedaldi E Subst Abus; 2008; 29(3):5-16. PubMed ID: 19042203 [TBL] [Abstract][Full Text] [Related]
8. Treatment of hepatitis C virus infection (HCV) after renal transplantation: implications for HCV-positive dialysis patients awaiting a kidney transplant. Kamar N; Ribes D; Izopet J; Rostaing L Transplantation; 2006 Oct; 82(7):853-6. PubMed ID: 17038897 [TBL] [Abstract][Full Text] [Related]
9. HCV kinetics, quasispecies, and clearance in treated HCV-infected and HCV/HIV-1-coinfected patients with hemophilia. Shire NJ; Horn PS; Rouster SD; Stanford S; Eyster ME; Sherman KE; Hepatology; 2006 Nov; 44(5):1146-57. PubMed ID: 17058240 [TBL] [Abstract][Full Text] [Related]
10. Assessment of efficacy of treatment in HCV: infection and disease. Chung RT J Hepatol; 2006; 44(1 Suppl):S56-9. PubMed ID: 16343683 [TBL] [Abstract][Full Text] [Related]
11. Treatment of chronic hepatitis C virus infection - Dutch national guidelines. de Bruijne J; Buster EH; Gelderblom HC; Brouwer JT; de Knegt RJ; van Erpecum KJ; Schalm SW; Bakker CM; Zaaijer HL; Janssen HL; Reesink HW; Neth J Med; 2008; 66(7):311-22. PubMed ID: 18663263 [TBL] [Abstract][Full Text] [Related]
12. [Effectiveness of antiviral therapy in patients with chronic hepatitis C treated by private practice gastroenterologists]. Hofmann WP; Bock H; Weber C; Tacke W; Pfaff R; Kihn R; Moog G; Kellner HU; Schöfer M; Frick B; Berg P; Rambow A; Friedrich-Rust M; Herrmann E; Sarrazin C; Zeuzem S Z Gastroenterol; 2006 Jan; 44(1):25-31. PubMed ID: 16397836 [TBL] [Abstract][Full Text] [Related]